Selected research
Industry Research
Adrenocorticotropic Hormone (ACTH) Industry Research Report 2026
Market perspective
The global Adrenocorticotropic Hormone (ACTH) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Adrenocorticotropic Hormone (ACTH) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Adrenocorticotropic Hormone (ACTH) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Adrenocorticotropic Hormone (ACTH) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Adrenocorticotropic Hormone (ACTH) include Novartis AG, Mylan N.V., Pfizer, Mallinckrodt and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Adrenocorticotropic Hormone (ACTH) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Adrenocorticotropic Hormone (ACTH) Market by Company
Novartis AG
Mylan N.V.
Pfizer
Mallinckrodt
Hikma Pharmaceuticals
Adrenocorticotropic Hormone (ACTH) Segment by Type
天然的
合成的
Adrenocorticotropic Hormone (ACTH) Segment by Application
医院药房
网上药房
零售药房
Adrenocorticotropic Hormone (ACTH) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adrenocorticotropic Hormone (ACTH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adrenocorticotropic Hormone (ACTH) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adrenocorticotropic Hormone (ACTH).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Adrenocorticotropic Hormone (ACTH) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Adrenocorticotropic Hormone (ACTH) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Adrenocorticotropic Hormone (ACTH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 天然的
- 合成的
Applications
- 医院药房
- 网上药房
- 零售药房
Companies covered
- Novartis AG
- Mylan N.V.
- Pfizer
- Mallinckrodt
- Hikma Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Adrenocorticotropic Hormone (ACTH) Market Size (2021-2032)
- 2.2.2 Global Adrenocorticotropic Hormone (ACTH) Sales (2021-2032)
- 2.2.3 Global Adrenocorticotropic Hormone (ACTH) Market Average Price (2021-2032)
- 2.3 Adrenocorticotropic Hormone (ACTH) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 天然的
- 2.3.3 合成的
- 2.4 Adrenocorticotropic Hormone (ACTH) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 医院药房
- 2.4.3 网上药房
- 2.4.4 零售药房
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Adrenocorticotropic Hormone (ACTH) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Adrenocorticotropic Hormone (ACTH) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Adrenocorticotropic Hormone (ACTH) Revenue of Manufacturers (2021-2026)
- 3.4 Global Adrenocorticotropic Hormone (ACTH) Average Price by Manufacturers (2021-2026)
- 3.5 Global Adrenocorticotropic Hormone (ACTH) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Adrenocorticotropic Hormone (ACTH), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Adrenocorticotropic Hormone (ACTH), Product Type & Application
- 3.8 Global Manufacturers of Adrenocorticotropic Hormone (ACTH), Established Date
- 3.9 Global Adrenocorticotropic Hormone (ACTH) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis AG
- 4.1.1 Novartis AG Company Information
- 4.1.2 Novartis AG Business Overview
- 4.1.3 Novartis AG Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis AG Adrenocorticotropic Hormone (ACTH) Product Portfolio
- 4.1.5 Novartis AG Recent Developments
- 4.2 Mylan N.V.
- 4.2.1 Mylan N.V. Company Information
- 4.2.2 Mylan N.V. Business Overview
- 4.2.3 Mylan N.V. Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan N.V. Adrenocorticotropic Hormone (ACTH) Product Portfolio
- 4.2.5 Mylan N.V. Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Adrenocorticotropic Hormone (ACTH) Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Mallinckrodt
- 4.4.1 Mallinckrodt Company Information
- 4.4.2 Mallinckrodt Business Overview
- 4.4.3 Mallinckrodt Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mallinckrodt Adrenocorticotropic Hormone (ACTH) Product Portfolio
- 4.4.5 Mallinckrodt Recent Developments
- 4.5 Hikma Pharmaceuticals
- 4.5.1 Hikma Pharmaceuticals Company Information
- 4.5.2 Hikma Pharmaceuticals Business Overview
- 4.5.3 Hikma Pharmaceuticals Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hikma Pharmaceuticals Adrenocorticotropic Hormone (ACTH) Product Portfolio
- 4.5.5 Hikma Pharmaceuticals Recent Developments
5 Global Adrenocorticotropic Hormone (ACTH) Market Scenario by Region
- 5.1 Global Adrenocorticotropic Hormone (ACTH) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Adrenocorticotropic Hormone (ACTH) Sales by Region: 2021-2032
- 5.2.1 Global Adrenocorticotropic Hormone (ACTH) Sales by Region: 2021-2026
- 5.2.2 Global Adrenocorticotropic Hormone (ACTH) Sales by Region: 2027-2032
- 5.3 Global Adrenocorticotropic Hormone (ACTH) Revenue by Region: 2021-2032
- 5.3.1 Global Adrenocorticotropic Hormone (ACTH) Revenue by Region: 2021-2026
- 5.3.2 Global Adrenocorticotropic Hormone (ACTH) Revenue by Region: 2027-2032
- 5.4 North America Adrenocorticotropic Hormone (ACTH) Market Facts & Figures by Country
- 5.4.1 North America Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2032)
- 5.4.3 North America Adrenocorticotropic Hormone (ACTH) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Adrenocorticotropic Hormone (ACTH) Market Facts & Figures by Country
- 5.5.1 Europe Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2032)
- 5.5.3 Europe Adrenocorticotropic Hormone (ACTH) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Adrenocorticotropic Hormone (ACTH) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Adrenocorticotropic Hormone (ACTH) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Adrenocorticotropic Hormone (ACTH) Market Facts & Figures by Country
- 5.7.1 South America Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2032)
- 5.7.3 South America Adrenocorticotropic Hormone (ACTH) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2032)
- 6.1.1 Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Adrenocorticotropic Hormone (ACTH) Sales Market Share by Type (2021-2032)
- 6.2 Global Adrenocorticotropic Hormone (ACTH) Revenue by Type (2021-2032)
- 6.2.1 Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Adrenocorticotropic Hormone (ACTH) Revenue Market Share by Type (2021-2032)
- 6.3 Global Adrenocorticotropic Hormone (ACTH) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2032)
- 7.1.1 Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Adrenocorticotropic Hormone (ACTH) Sales Market Share by Application (2021-2032)
- 7.2 Global Adrenocorticotropic Hormone (ACTH) Revenue by Application (2021-2032)
- 7.2.1 Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Adrenocorticotropic Hormone (ACTH) Revenue Market Share by Application (2021-2032)
- 7.3 Global Adrenocorticotropic Hormone (ACTH) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Adrenocorticotropic Hormone (ACTH) Value Chain Analysis
- 8.1.1 Adrenocorticotropic Hormone (ACTH) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Adrenocorticotropic Hormone (ACTH) Production Mode & Process
- 8.2 Adrenocorticotropic Hormone (ACTH) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Adrenocorticotropic Hormone (ACTH) Distributors
- 8.2.3 Adrenocorticotropic Hormone (ACTH) Customers
9 Global Adrenocorticotropic Hormone (ACTH) Analyzing Market Dynamics
- 9.1 Adrenocorticotropic Hormone (ACTH) Industry Trends
- 9.2 Adrenocorticotropic Hormone (ACTH) Industry Drivers
- 9.3 Adrenocorticotropic Hormone (ACTH) Industry Opportunities and Challenges
- 9.4 Adrenocorticotropic Hormone (ACTH) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst